106 related articles for article (PubMed ID: 20940282)
1. Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes.
Janse M; Weersma RK; Sudan DL; Festen EA; Wijmenga C; Dijkstra G; Mercer D
Gut; 2011 Jun; 60(6):877-8; author reply 878-9. PubMed ID: 20940282
[No Abstract] [Full Text] [Related]
2. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome.
Ningappa M; Higgs BW; Weeks DE; Ashokkumar C; Duerr RH; Sun Q; Soltys KA; Bond GJ; Abu-Elmagd K; Mazariegos GV; Alissa F; Rivera M; Rudolph J; Squires R; Hakonarson H; Sindhi R
Am J Gastroenterol; 2011 Jan; 106(1):157-65. PubMed ID: 20959815
[TBL] [Abstract][Full Text] [Related]
3. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine.
Fishbein T; Novitskiy G; Mishra L; Matsumoto C; Kaufman S; Goyal S; Shetty K; Johnson L; Lu A; Wang A; Hu F; Kallakury B; Lough D; Zasloff M
Gut; 2008 Mar; 57(3):323-30. PubMed ID: 17965060
[TBL] [Abstract][Full Text] [Related]
4. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease.
Schäffler H; Schneider N; Hsieh CJ; Reiner J; Nadalin S; Witte M; Königsrainer A; Blumenstock G; Lamprecht G
Clin Nutr; 2013 Dec; 32(6):1029-35. PubMed ID: 23562557
[TBL] [Abstract][Full Text] [Related]
5. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
[TBL] [Abstract][Full Text] [Related]
6. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
7. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
Rogler G; Holler E
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):62-3. PubMed ID: 16265048
[No Abstract] [Full Text] [Related]
8. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
Angelberger S; Reinisch W; Dejaco C; Miehsler W; Waldhoer T; Wehkamp J; Lichtenberger C; Schaeffeler E; Vogelsang H; Schwab M; Teml A
Am J Gastroenterol; 2008 May; 103(5):1197-202. PubMed ID: 18371140
[TBL] [Abstract][Full Text] [Related]
9. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
10. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
11. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
[TBL] [Abstract][Full Text] [Related]
12. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
Barreiro-de Acosta M; Peña AS
Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
[TBL] [Abstract][Full Text] [Related]
14. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
16. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
[TBL] [Abstract][Full Text] [Related]
17. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
18. NOD2 mutations predict the risk for surgery in pediatric-onset Crohn's disease.
Lacher M; Helmbrecht J; Schroepf S; Koletzko S; Ballauff A; Classen M; Uhlig H; Hubertus J; Hartl D; Lohse P; von Schweinitz D; Kappler R
J Pediatr Surg; 2010 Aug; 45(8):1591-7. PubMed ID: 20713205
[TBL] [Abstract][Full Text] [Related]
19. [Small bowel transplantation as a treatment option for intestinal failure in children and adults].
Dijkstra G; Rings EH; van Dullemen HM; Bijleveld CM; Meessen NE; Karrenbeld A; Hofker HS; Porte RJ; Naber AH; Ploeg RJ
Ned Tijdschr Geneeskd; 2005 Feb; 149(8):391-8. PubMed ID: 15751317
[TBL] [Abstract][Full Text] [Related]
20. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
